Fingerprint
Dive into the research topics of 'Combined-modality treatment for stage IIIa (N2) non-small cell lung cancer: A National Cancer Institute Intergroup study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Combined-modality treatment for stage IIIa (N2) non-small cell lung cancer: A National Cancer Institute Intergroup study
Research output: Contribution to journal › Article › peer-review
7
Scopus
citations